Akèy › Ensifizans entestinal › Nebraska
Etid klinik pou Ensifizans entestinal nan Nebraska
3 etid pou Ensifizans entestinal ap chèche patisipan nan sit nan Nebraska.
Vil nan Nebraska
Tèks ofisyèl etid la (Anglè)
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
- Lied Transplant Center at Nebraska Medical Center, Omaha
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Sep 29, 2026 · NCT07197944Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
- Nebraska Medicine, Omaha
Ap rekriteFaz 2/3
Laj 12 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06910943KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
- University of Nebraska Medical Center, Omaha
Ap rekrite
4 Weeks – 18 Years · Tout sèks · Mizajou Jun 4, 2026 · NCT05879835Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.